MH, D., B, S., W, H., CY, O., S, H., J, H., . . . A, N. (2026). Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors. Journal for immunotherapy of cancer, 14(6), . https://doi.org/10.1136/jitc-2025-014768
Chicago Style (17th ed.) CitationMH, Derbala, et al. "Artificial Intelligence-guided Analysis of the Tumor Microenvironment Predicts Response to Pembrolizumab in Rare Tumors." Journal for Immunotherapy of Cancer 14, no. 6 (2026). https://doi.org/10.1136/jitc-2025-014768.
MLA (9th ed.) CitationMH, Derbala, et al. "Artificial Intelligence-guided Analysis of the Tumor Microenvironment Predicts Response to Pembrolizumab in Rare Tumors." Journal for Immunotherapy of Cancer, vol. 14, no. 6, 2026, https://doi.org/10.1136/jitc-2025-014768.